Trade Summary

5 months ago, Bunka Christopher, serving as Dir at Lexaria Bioscience Corp. (LEXX), purchased 27,500 shares at $0.92 per share, for a total transaction value of $25,241.00. Following this transaction, Bunka Christopher now holds 909,867 shares of LEXX.

This purchase represents a 3.00% increase in Bunka Christopher's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, July 29, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, July 30, 2025, 1 day after the trade was made.

Lexaria Bioscience Corp. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.